SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-20-009688
Filing Date
2020-11-09
Accepted
2020-11-09 08:15:34
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_093020.htm 10-Q 471255
2 PURCHASE AND SALE AGREEMENT ex10-01.htm EX-10.01 73575
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 17129
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 17633
5 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER ex32-01.htm EX-32.01 8410
  Complete submission text file 0001387131-20-009688.txt   3940061

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tnxp-20200930.xml EX-101.INS 617178
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20200930.xsd EX-101.SCH 55817
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnxp-20200930_cal.xml EX-101.CAL 45299
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnxp-20200930_def.xml EX-101.DEF 193089
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20200930_lab.xml EX-101.LAB 382797
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20200930_pre.xml EX-101.PRE 277408
Mailing Address 28 MAIN STREET CHATHAM NJ 07928
Business Address 28 MAIN STREET CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 201296210
SIC: 2834 Pharmaceutical Preparations